HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Radiotherapy and Oncology

• Publication date

  2016-12-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.radonc.2016.11.008PMID 27913065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments☆

  2017cited by this paper
• Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.

  2016cited by this paper
• Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG

  2016cited by this paper
• Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status.

  2016cited by this paper
• Impact of Expression of CD44, a Cancer Stem Cell Marker, on the Treatment Outcomes of Intensity Modulated Radiation Therapy in Patients With Oropharyngeal Squamous Cell Carcinoma.

  2016cited by this paper
• CD8+ tumour‐infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK‐ROG)

  2016cited by this paper
• The impact of hypoxia and its modification of the outcome of radiotherapy

  2016cited by this paper
• Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials

  2016cited by this paper
• Radiation oncology in the era of precision medicine

  2016cited by this paper
• Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy

  2016cited by this paper
• HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC.

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• High-grade acute organ toxicity and p16INK4A expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma

  2015cited by this paper
• The effect of tumor volume on radiotherapy outcome and correlation with other prognostic factors in patients with T2 supraglottic cancer

  2014cited by this paper
• HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

  2014cited by this paper
• Impact of initial tumor volume on radiotherapy outcome in patients with T2 glottic cancer

  2014cited by this paper
• Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets

  2014cited by this paper
• Evolution of the cancer stem cell model.

  2014cited by this paper
• HPV in

  2014cited by this paper
• Indications for postoperative radiotherapy in laryngeal carcinoma: A panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study

  2014cited by this paper
• Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer.

  2014cited by this paper
• Hypoxia as a biomarker for radioresistant cancer stem cells

  2014cited by this paper
• HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity.

  2013cited by this paper
• Enhanced radiation sensitivity in HPV-positive head and neck cancer.

  2013cited by this paper
• Volumetric stratification of cT4 stage head and neck cancer

  2013cited by this paper
• Impact of primary tumor volume on local control after definitive radiotherapy for head and neck cancer

  2013cited by this paper
• GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: subgroup analysis of the prospective randomized CHARTWEL trial.

  2013cited by this paper
• A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer

  2013cited by this paper
• Individualization of cancer treatment from radiotherapy perspective

  2012cited by this paper
• Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck.

  2012cited by this paper
• Novel biomarker panel predicts prognosis in human papillomavirus‐negative oropharyngeal cancer

  2012cited by this paper
• Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer.

  2011cited by this paper
• The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial.

  2011cited by this paper
• Prognostic Value of Radiobiological Hypoxia during Fractionated Irradiation for Local Tumor Control

  2011cited by this paper
• CD44: A Cancer Stem Cell–Related Biomarker with Predictive Potential for Radiotherapy

  2010cited by this paper
• Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation.

  2010cited by this paper
• CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer

  2010cited by this paper
• Generating specificity and diversity in the transcriptional response to hypoxia

  2009cited by this paper
• Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.

  2009cited by this paper
• Exploring the role of cancer stem cells in radioresistance

  2008cited by this paper
• Hypoxic radiosensitization: adored and ignored.

  2007cited by this paper
• Tumor progression in waiting time for radiotherapy in head and neck cancer.

  2007cited by this paper
• Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers.

  2007cited by this paper
• Clinical implications of human papillomavirus in head and neck cancers.

  2006cited by this paper
• Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.

  2005cited by this paper
• Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.

  2004cited by this paper
• An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.

  2003cited by this paper
• Human papillomavirus positive squamous cell carcinoma of the oropharynx

  2001cited by this paper
• Tumor volume: a basic and specific response predictor in radiotherapy.

  1998cited by this paper
• Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.

  1996cited by this paper
• Tumor volume and local control probability: clinical data and radiobiological interpretations.

  1996cited by this paper
• The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors.

  1995cited by this paper
• The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography.

  1995cited by this paper
• Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study.

  1993cited by this paper
• Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units.

  1990cited by this paper
• The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.

  1953cited by this paper

• A tumor DNA-Methylome derived signature of Hypoxia Identifies HPV-negative head and neck cancer patients at risk for distant metastasis after postoperative radiochemotherapy (PORT-C).

  2026cites this paper
• Application of a preclinical 18-gene classifier to patients with locally advanced HNSCC

  2025cites this paper
• Reduced field-of-view DWI outperforms conventional DWI in assessing tumor heterogeneity and HPV status in head and neck cancer

  2025cites this paper
• Deep Learning Predicts Survival Across Squamous Tumor Entities From Routine Pathology: Insights from Head and Neck, Esophagus, Lung and Cervical Cancer.

  2025cites this paper
• Expression of MASTL (Greatwall) associates with good prognosis and response to radiotherapy in pharyngeal squamous cell carcinoma

  2025cites this paper
• A New Model to Investigate the Action of Radiation and Cigarette Smoke on Head and Neck Cancer Cells

  2025cites this paper
• Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline Update.

  2025cites this paper
• Longitudinal assessment of diffusion-weighted imaging during magnetic resonance-guided radiotherapy in head and neck cancer

  2025cites this paper
• Optimizing Prognostic Assessment in High‐Risk Head and Neck Squamous Cell Carcinomas: The Impact of Tumor Budding and a Novel Histomorphological Scoring System

  2025cites this paper
• Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - a DAHANCA 19 study.

  2024cites this paper
• Clinical validation of a prognostic preclinical magnetic resonance imaging biomarker for radiotherapy outcome in head-and-neck cancer.

  2024cites this paper
• Integrated analysis of disulfidptosis-related genes SLC7A11, SLC3A2, RPN1 and NCKAP1 across cancers

  2024cites this paper
• A novel lineage-tracing tool reveals that hypoxic tumor cells drive tumor relapse after radiotherapy

  2024cites this paper
• Transcriptomic and epigenetic landscape of nimorazole-enhanced radiochemotherapy in head and neck cancer.

  2024cites this paper
• Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.

  2024cites this paper
• Potential role of lymphocyte CD44 in determining treatment selection between stereotactic body radiotherapy and surgery for early-stage non-small-cell lung cancer.

  2024cites this paper
• Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer

  2024cites this paper
• Prognostic Value of Interim CT-based Peritumoral and Intratumoral Radiomics in Laryngeal and Hypopharyngeal Cancer Patients Undergoing Definitive Radiotherapy.

  2023cites this paper
• The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: robust gene signature correlates with radiotherapy outcome in patients and xenografts.

  2023cites this paper
• Proton Compared to X-Irradiation Induces Different Protein Profiles in Oral Cancer Cells and Their Derived Extracellular Vesicles

  2023cites this paper
• CD98 heavy chain as a prognostic biomarker and target for cancer treatment

  2023cites this paper
• Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors

  2023cites this paper
• Impact of MRI on target volume definition in head and neck cancer patients

  2023cites this paper
• Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts

  2023influential citation
• The influence of tumor volume on the risk of distant metastases in head and neck squamous cell carcinomas.

  2023cites this paper
• Prognosis to Radiation Unlocked: How Hypoxia Methylome may hold the Key in HNSCC.

  2023cites this paper
• Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity

  2023cites this paper
• Using 3D deep features from CT scans for cancer prognosis based on a video classification model: A multi-dataset feasibility study.

  2023cites this paper
• DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy

  2023influential citation
• Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction

  2023cites this paper
• CD44, γ-H2AX, and p-ATM Expressions in Short-Term Ex Vivo Culture of Tumour Slices Predict the Treatment Response in Patients with Oral Squamous Cell Carcinoma

  2022cites this paper
• Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy—A Systematic Review

  2022cites this paper
• Cancer stem cells (CSCs): key player of radiotherapy resistance and its clinical significance

  2022cites this paper
• Predicting tumour radiosensitivity to deliver precision radiotherapy

  2022cites this paper
• Lokal fortgeschrittene Kopf-Hals-Tumoren: Therapiekonzepte und neue Ansätze

  2022cites this paper
• Tumor buster - where will the CAR-T cell therapy ‘missile’ go?

  2022cites this paper
• Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC

  2022cites this paper
• FedPseudo: Pseudo value-based Deep Learning Models for Federated Survival Analysis

  2022cites this paper
• A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT

  2022cites this paper
• Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer – A scoping review

  2022cites this paper
• Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy

  2022cites this paper
• Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia

  2022cites this paper
• Analyses of molecular subtypes and their association to mechanisms ofradioresistance in patients with HPV-negative HNSCC treated bypostoperative radiochemotherapy.

  2022cites this paper
• PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology

  2022cites this paper
• The COMPLETE trial: HolistiC early respOnse assessMent for oroPharyngeaL cancEr paTiEnts; Protocol for an observational study

  2022cites this paper
• Adherence to a priori-Defined Diet Quality Indices Throughout the Early Disease Course Is Associated With Survival in Head and Neck Cancer Survivors: An Application Involving Marginal Structural Models

  2022cites this paper
• CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity

  2022cites this paper
• Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical setting.

  2022cites this paper
• Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - hypothesis generation on a multicentre cohort of the DKTK-ROG.

  2022cites this paper
• Practical Challenges in Differentially-Private Federated Survival Analysis of Medical Data

  2022cites this paper
• No time to die – BiGART is back. The 20th Acta Oncologica Symposium – BIGART 2021

  2022cites this paper
• Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma

  2021influential citation
• Convolutional neural network in nasopharyngeal carcinoma: how good is automatic delineation for primary tumor on a non-contrast-enhanced fat-suppressed T2-weighted MRI?

  2021cites this paper
• Resistance of Hypoxic Cells to Ionizing Radiation Is Mediated in Part via Hypoxia-Induced Quiescence

  2021cites this paper
• Identification of prognostic marker genes in head and neck squamous cell carcinoma: a study based on TCGA database and experimental validation.

  2021cites this paper
• Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas

  2021cites this paper
• Radiooncological View on Therapy Outcome after Multidisciplinary Treatment of Sinonasal Tumors

  2021cites this paper
• Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L

  2021cites this paper
• Altering Radiation Response with Time, Volume and Fractionation

  2021cites this paper
• Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma-Treatment Modalities

  2021cites this paper
• Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies.

  2021cites this paper
• Tumor DNA‐methylome derived epigenetic fingerprint identifies HPV‐negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy

  2021cites this paper
• Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients

  2021cites this paper
• Molekulare Prädiktion für die Radio(chemo)therapie von Kopf-Hals-Plattenepithelkarzinomen

  2021cites this paper
• The Prognostic Value of Cancer Stem Cell Markers in Cervical Cancer: A Systematic Review and Meta-Analysis

  2021cites this paper
• What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond

  2020cites this paper
• Influence of Tumor Necrosis on Treatment Sensitivity and Long-term Survival in Nasopharyngeal Carcinoma.

  2020cites this paper
• Preclinical In Vivo Evaluation of Novel Radiosensitizers by Local Tumor Control Experiments

  2020cites this paper
• Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC

  2020cites this paper
• 2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma

  2020cites this paper
• Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype

  2020cites this paper
• Radiomic biomarkers for head and neck squamous cell carcinoma

  2020cites this paper
• ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

  2020cites this paper
• Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224).

  2020cites this paper
• Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy.

  2020cites this paper
• Non contrast-enhanced imaging as a replacement for contrast-enhanced imaging for MRI automatic delineation of nasopharyngeal carcinoma

  2020cites this paper
• Comparison of GeneChip, nCounter and real-time polymerase chain reaction based gene expressions predicting loco-regional tumour control after primary and postoperative radiochemotherapy in head and neck squamous cell carcinoma.

  2020cites this paper
• Specific requirements for translation of biological research into clinical radiation oncology

  2020cites this paper
• Prognostic value of a 15-gene hypoxia classifier in oropharyngeal cancer treated with accelerated chemoradiotherapy

  2020cites this paper
• The Role of Cancer Stem Cells in Radiation Resistance

  2020cites this paper
• Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy.

  2020cites this paper
• Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation

  2020cites this paper
• Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”

  2020cites this paper
• Which characteristics can be expected from p16+-squamous cell carcinomas of the posterior oral cavity and oropharynx? - Distinctive results from Central Germany.

  2020cites this paper
• Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

  2020cites this paper
• Prognostic value of immune‐related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma

  2020influential citation
• Cancer stem cells in radiation response: current views and future perspectives in radiation oncology

  2019influential citation
• Prediction of survival of HPV16-negative, p16-negative oral cavity cancer patients using a 13-gene signature: A multicenter study using FFPE samples.

  2019cites this paper
• Competing risks in survival data analysis.

  2019cites this paper
• Cancer Stem Cells, CD44, and Outcomes Following Chemoradiation in Locally Advanced Cervical Cancer: Results From a Prospective Study.

  2019cites this paper
• The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity

  2019cites this paper
• Comparable radiation response of ex vivo and in vivo irradiated tumor samples determined by residual γH2AX.

  2019cites this paper
• CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer.

  2019cites this paper
• Immunologic mediators of outcome for irradiated oropharyngeal carcinoma based on human papillomavirus status.

  2019cites this paper
• Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy

  2019cites this paper
• Study on the effect of XRCC 1 silencing on radiotherapeutic response of nasopharyngeal carcinoma cells and its mechanism

  2019cites this paper
• Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.

  2019cites this paper
• Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review.

  2019cites this paper
• Heterogeneity of Head and Neck Squamous Cell Carcinoma Stem Cells.

  2019cites this paper